Biogen stock explodes higher after potential 'mega blockbuster' Alzheimer's drug study

By yahoo! finance
| September 28, 2022

Biogen stock is booming amid as Wall Street speculates about a potential profit boom after a promising study detailed the company's new Alzheimer's drug in partnership with Japan's Eisai.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...